As of 2025-07-04, the Fair Value of RegeneRx Biopharmaceuticals Inc (RGRX) is -5.63 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of RegeneRx Biopharmaceuticals Inc is -2,814,425.00%.
With the market price of 0.00 USD and our fair value calculation, RegeneRx Biopharmaceuticals Inc (RGRX) is not a good investment. Investing in RGRX stocks now will result in a potential loss of 2,814,425.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -1.99 | -1.40 | -1.52 | -1.60 | -1.73 | -1.65 |
| YoY growth | -795.85% | 29.56% | -8.48% | -4.88% | -8.12% | -157.56% |
| Market Cap (mil) | 0.00 |
| P/E | |
| Forward P/E |
| EPS | -1.13 |
| Avg earnings growth rate | -157.56% |
| TTM earnings | -1.69 |